Work

Cobalt-Induced Ototoxicity Treated With Corticosteroids, Chelation, and Hyperbaric Oxygen Therapy

Year: 2026
Type: article
Study design: Case Report
Abstract: Systemic cobalt toxicity, including sensorineural hearing loss, may occur in patients with cobalt-chromium (CoCr) hip prostheses. This report describes a 45-year-old woman who underwent unilateral total hip revision surgery due to mechanical failure of her original implant. Intraoperative findings included fractures of her original ceramic prosthesis that were debrided. A new CoCr dual mobility liner and femoral head were implanted. Within a few months postoperatively, she developed sensorineural hearing loss and was diagnosed with markedly elevated plasma cobalt and chromium concentrations. She underwent a second revision procedure, but her hearing loss persisted. After treatment with prednisone, succimer, N-acetylcysteine (NAC), and hyperbaric oxygen therapy, her hearing acuity improved. For patients with arthroprosthetic cobalt toxicity, prosthesis explantation and revision are primary treatments that often result in symptom improvement, but patients who experience persistent ototoxicity may benefit from additional therapies to improve symptoms and reduce the systemic cobalt burden.
Source: Cureus
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7234922882
FWCI:
Cites: 18
Cited by:
Related to: 10